UPDATE 1-Akorn Inc's Hi-Tech Pharmacal infringes Allergan glaucoma drug patents
August 04, 2015 at 11:00 AM EDT
NEW YORK, Aug 4 (Reuters) - An Akorn Inc unit's proposed generic glaucoma drug infringed three Allergan Inc patents on its Lumigan topical treatment for the eye disease, a U.S. appeals court ruled on Tuesday.
